BIODESIX INC — Director's Dealing 2020

Oct 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: Cowie Robin Harper (CFO, Sec?y & Treasurer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$2.62	2021-04-21	Common Stock (2526)		Direct
Stock Options (Right to buy)	$4.40	2024-02-03	Common Stock (10107)		Direct
Stock Options (Right to buy)	$4.40	2025-04-08	Common Stock (6738)		Direct
Stock Options (Right to buy)	$0.84	2026-04-06	Common Stock (35377)		Direct
Stock Options (Right to buy)	$0.84	2026-04-06	Common Stock (8172)		Direct
Stock Options (Right to buy)	$0.42	2027-05-15	Common Stock (16846)		Direct
Stock Options (Right to buy)	$0.42	2028-04-03	Common Stock (21058)		Direct
Stock Options (Right to buy)	$0.78	2028-12-31	Common Stock (35377)		Direct
Stock Options (Right to buy)	$0.78	2030-04-14	Common Stock (30323)		Direct

Footnotes

F1: This option vested 40% on March 28, 2013, and the remaining 60% in 36 successive, equal monthly installments measured from March 28, 2013.

F2: This option vested in 60 successive, equal monthly installments measured from January 1, 2014.

F3: This option vested in 60 successive, equal monthly installments measured from January 1, 2015.

F4: This option vests in 60 successive, equal monthly installments measured from January 1, 2016.

F5: This option vests in 60 successive, equal monthly installments measured from January 1, 2017.

F6: This option vests in 60 successive, equal monthly installments measured from January 1, 2018.

F7: This option vests twenty-one sixtieths (21/60ths) on October 1, 2020, the remaining balance vests in 39 successive, equal monthly installments measured from October 1, 2020.

F8: This option vests in 60 successive, equal monthly installments measured from January 1, 2020.